123 related articles for article (PubMed ID: 16189477)
1. Attenuation of morphine withdrawal signs by a D1 receptor agonist in the locus coeruleus of rats.
Dizgah IM; Karimian SM; Zarrindast MR; Sohanaki H
Neuroreport; 2005 Oct; 16(15):1683-6. PubMed ID: 16189477
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of morphine withdrawal signs by muscimol in the locus coeruleus of rats.
Mirzaii-Dizgah I; Karimian SM; Hajimashhadi Z; Riahi E; Ghasemi T
Behav Pharmacol; 2008 May; 19(3):171-5. PubMed ID: 18469534
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats.
Riahi E; Mirzaii-Dizgah I; Karimian SM; Sadeghipour HR; Dehpour AR
Behav Brain Res; 2009 Jan; 196(1):11-4. PubMed ID: 18634832
[TBL] [Abstract][Full Text] [Related]
4. Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.
Chartoff EH; Barhight MF; Mague SD; Sawyer AM; Carlezon WA
Psychopharmacology (Berl); 2009 Jun; 204(2):227-39. PubMed ID: 19148621
[TBL] [Abstract][Full Text] [Related]
5. Injection of D1 receptor antagonist SCH23390 into the periaqueductal gray attenuates morphine withdrawal symptoms in rats.
Liu Q; Du G; Xiao R; Liu Y; Cao K; Du X; Tang S; Huang W; Wang X
Neurosci Lett; 2020 Jan; 714():134502. PubMed ID: 31639423
[TBL] [Abstract][Full Text] [Related]
6. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
Farzin D
Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
[TBL] [Abstract][Full Text] [Related]
7. The effects of dopamine receptor agents on naloxone-induced jumping behaviour in morphine-dependent mice.
Zarrindast MR; Habibi M; Borzabadi S; Fazli-Tabaei S; Hossein Yahyavi S; Rostamin P
Eur J Pharmacol; 2002 Sep; 451(3):287-93. PubMed ID: 12242090
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal.
Chartoff EH; Mague SD; Barhight MF; Smith AM; Carlezon WA
J Neurosci; 2006 Jun; 26(24):6450-7. PubMed ID: 16775132
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.
Azizi H; Mirnajafi-Zadeh J; Rohampour K; Semnanian S
Neurosci Lett; 2010 Oct; 482(3):255-9. PubMed ID: 20667500
[TBL] [Abstract][Full Text] [Related]
10. The blockade of GABAA receptors attenuates the inhibitory effect of orexin type 1 receptors antagonist on morphine withdrawal syndrome in rats.
Davoudi M; Azizi H; Mirnajafi-Zadeh J; Semnanian S
Neurosci Lett; 2016 Mar; 617():201-6. PubMed ID: 26879836
[TBL] [Abstract][Full Text] [Related]
11. Central blockade of orexin type 1 receptors reduces naloxone induced activation of locus coeruleus neurons in morphine dependent rats.
Aghajani N; Pourhamzeh M; Azizi H; Semnanian S
Neurosci Lett; 2021 Jun; 755():135909. PubMed ID: 33892002
[TBL] [Abstract][Full Text] [Related]
12. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
[TBL] [Abstract][Full Text] [Related]
13. The ameliorative effects and underlying mechanisms of dopamine D1-like receptor agonist SKF38393 on Aβ
Zang X; Cheng ZY; Sun Y; Hua N; Zhu LH; He L
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():250-261. PubMed ID: 28939187
[TBL] [Abstract][Full Text] [Related]
14. Role of D1 dopamine receptors of the ventral pallidum in inhibitory avoidance learning.
Péczely L; Ollmann T; László K; Kovács A; Gálosi R; Szabó Á; Karádi Z; Lénárd L
Behav Brain Res; 2014 Aug; 270():131-6. PubMed ID: 24815313
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
Hall S; Milne B; Jhamandas K
Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the dorsal hippocampal dopamine D1 receptors inhibits the scopolamine-induced state-dependent learning in rats.
Piri M; Rostampour M; Nasehi M; Zarrindast MR
Neuroscience; 2013 Nov; 252():460-7. PubMed ID: 23933216
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus.
Hong M; Milne B; Jhamandas K
Brain Res; 1993 Sep; 623(1):131-41. PubMed ID: 8221081
[TBL] [Abstract][Full Text] [Related]
18. PKC inhibitor reversed the suppressive effect of orexin-A on IPSCs of locus coeruleus neurons in naloxone-induced morphine withdrawal.
Davoudi M; Vijeepallam K; Azizi H; Mirnajafi-Zadeh J; Semnanian S
J Neural Transm (Vienna); 2019 Nov; 126(11):1425-1435. PubMed ID: 31493096
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of the locus coeruleus in inhibition by prostanoid EP(3) receptor-selective agonists of morphine withdrawal syndrome in rats.
Nakagawa T; Masuda T; Watanabe T; Minami M; Satoh M
Eur J Pharmacol; 2000 Mar; 390(3):257-66. PubMed ID: 10708732
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of antiamnestic effects of blockade and activation of dopamine D1 receptors after stress stimulation in mice.
Dubrovina NI
Bull Exp Biol Med; 2012 Feb; 152(4):413-5. PubMed ID: 22803099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
